FibroBiologics, Inc. Conversion of Stock, Shares Issued
FibroBiologics, Inc. (FBLG) had Conversion of Stock, Shares Issued of 118.99 thousand shares as of 2025-01-07, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2026-02-24
- FibroBiologics, Inc. conversion of stock, shares issued for fiscal 2024 was 4.81M shares.
- FibroBiologics, Inc. conversion of stock, shares issued for fiscal 2022 was 801.14K shares.
| Period end | Conversion of Stock, Shares Issued | Conversion of Stock, Shares Issued 12 month |
|---|---|---|
| 2025-01-07 | 118.99K shares 10-K · filed 2026-02-24 | |
| 2024-12-31 | 4.81M shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | 801.14K shares 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 |